Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2003
09/18/2003WO2003076646A2 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene
09/18/2003WO2003076643A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
09/18/2003WO2003076637A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
09/18/2003WO2003076635A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
09/18/2003WO2003076630A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
09/18/2003WO2003076628A1 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide
09/18/2003WO2003076627A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
09/18/2003WO2003076624A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
09/18/2003WO2003076622A1 PRESYNAPTIC PROTEIN p120
09/18/2003WO2003076619A1 Modified gene-silencing rna and uses thereof
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076616A1 Dna encoding lactate dehydrogenase and utilization thereof
09/18/2003WO2003076611A1 Alleles of the acea gene from coryneform bacteria
09/18/2003WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/18/2003WO2003076463A2 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance
09/18/2003WO2003076452A2 Temperature sensitive mutant derivatives of the broad host range plasmid pbhr1
09/18/2003WO2003076351A1 Method for treatment of sewage plant sludges by a fungal process
09/18/2003WO2003075840A2 Human antibodies specific to kdr and uses thereof
09/18/2003WO2003075747A2 Contrast agents for magnetic resonance imaging and methods related thereto
09/18/2003WO2003075676A1 Probiotic delivery system
09/18/2003WO2003075669A2 Food fermentation with lactic acid bacteria
09/18/2003WO2003075655A2 Novel vip3 toxins and methods of use
09/18/2003WO2003060068A3 Oxa1p enhanced protein secretion
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
09/18/2003WO2003035861A3 Thrombin-cleavable chimeric proteins
09/18/2003WO2003023013A3 Novel nucleic acids and polypeptides
09/18/2003WO2003006644A3 Lipase/acyltransferase
09/18/2003WO2003004675A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
09/18/2003WO2003004671A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
09/18/2003WO2002103015A3 Abca10 transporter
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002060914A3 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002057458A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease
09/18/2003WO2002040641A3 Binary bac vector and uses thereof
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002000687A9 Antimicrobial peptides and methods of use thereof
09/18/2003US20030177530 From cereals; transgenic plant; heat resistance; genetic engineering
09/18/2003US20030177527 Nucleotide sequences coding signal transduction components in durable and broad-range resistance strategies based on plant defence
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176675 TyrA genes and uses thereof
09/18/2003US20030176673 Fermentation of fusion protein; genetic engineering
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176655 Genetic engineering; cardiovascular disorders
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176648 Ion channel
09/18/2003US20030176355 Administering protein and biologically active substance; formulation acquires a non-liquid form under physiological conditions and biologically active substance is delivered from non-liquid to localized site
09/18/2003US20030176352 Peptides and related compounds having thrombopoietic activity
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent
09/18/2003US20030176342 Novel potassium channel
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176338 Novel serine-threonine kinase
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176304 Protease variants and compositions
09/18/2003US20030175977 Bacteria reproduced in Deinococcus; endogenous plasmids
09/18/2003US20030175970 Digestion using restriction enzyme; gel purification
09/18/2003US20030175940 Cell-wall degrading enzyme variants
09/18/2003US20030175937 Cathepsin O2 protease
09/18/2003US20030175936 Poly - gamma - glutamic acid decomposing enzyme gene and method for producing poly - gamma - glutamic acid
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175933 Mutants; detergents; active materials; oxidation resistance
09/18/2003US20030175929 Recombinant human creatine kinase heterodimer with solution-stability
09/18/2003US20030175927 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003US20030175923 Human transferase proteins
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175916 Nucleic acid which codes glycerol dehydratase
09/18/2003US20030175913 Anticancer agents; adding stimulants to plant cell culture
09/18/2003US20030175912 Method of producing L-serine by fermentation
09/18/2003US20030175911 Process for the preparation of L-amino acids with amplification of the zwf gene
09/18/2003US20030175910 Whole cell catalyst
09/18/2003US20030175909 Novel thermostable galactose isomerase and tagatose production thereby
09/18/2003US20030175902 Methods for producing hyaluronan in a recombinant host cell
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175896 Use of CYP52A2A promoter to increase gene expression in yeast
09/18/2003US20030175895 Chemokine
09/18/2003US20030175893 Metabolism mutant; nucleic acid cassette
09/18/2003US20030175892 Amino acid sequences encoding serine protease used in cleaning composition
09/18/2003US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use
09/18/2003US20030175886 Used to prevent production of reactive oxygen radicals, oxidative stress
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175862 Engineered open reading frame for p53
09/18/2003US20030175859 Fluorescent proteins
09/18/2003US20030175855 Human sdf-5 protein and compositions
09/18/2003US20030175854 System and method for gene expression in thermus strains
1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1489